Abstract
For patients with leukemia, bone marrow transplantation provides a mechanism for avoiding the lethal consequences of marrow damage, making it possible to give “superlethal” chemoradiotherapy, and if the immune system of the transplanted marrow is capable of exerting an antileukemic effect, marrow transplantation may also be effective as a form of adoptive immunotherapy. A review of the earlier literature regarding marrow transplantation has been published [1].
These investigations were supported in part by Grant CA 18029, awarded by the National Cancer Institute, DHHS. Dr. Thomas is the recipient of Research Career Award AI 02425 from the National Institute of Allergy and Infectious Diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation. N Engl J Med 292:832–843, 895–902, 1975
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511–533, 1977
Gale RP: Clinical trials of bone marrow transplantation in leukemia, In: Gale RP, Fox CF (eds): Biology of Bone Marrow Transplantation. New York, Academic Press, 1980, pp 11–27
Thomas ED, Sanders JE, Flournoy N, Johnson FL, Buckner CD, Clift RA, Fefer A, Goodell BW, Storb R, Weiden PL: Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54:468–476, 1979
Thomas ED, Sanders JE, Flournoy N, Johnson FL, Buckner CD, Clift RA, Fefer A, Goodell BW, Storb R, Weiden PL: Marrow transplantation for patients with acute lymphoblastic leukemia: A long-term follow-up. Blood 62:1139–1141, 1983
Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R: A comparison of marrow transplantation to chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 305:846–851, 1981
Woods WG, Nesbit ME, Ramsay NKC, Krivit W, Kim TH, Goldman A, McGlave PB, Kersey JH: Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: Determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team). Blood 61:1182–1189, 1983
Rai KR, Holland JF, Glidewell OJ, Wienberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Carey RW, Cooper MR, Haurani F, Hutchison JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, Mclntyre OR, Kaan SK: Treatment of acute myelocytic leukemia: A study by cancer and leukemia group B. Blood 58:1203–1212, 1981
Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute non-lymphoblastic leukemia in first remission. N Engl J Med 301:597–599, 1979
Thomas ED, Clift RA, Buckner CD for the Seattle Marrow Transplantat Team: Marrow transplantation for patients with acute nonlymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 66:1463–1466, 1982
Thomas ED: Marrow transplant for acute nonlymphoblastic leukemia in first remission: A follow-up. (Letter.) N Engl J Med 308:1539–1540, 1983
Thomas ED, Clift RA, Hersman J, Sanders JE, Stewart P, Buckner CD, Fefer A, McGuffin R, Smith JW, Storb R: Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or singledose irradiation. Int J Rad One Biol Phys 8:817–821, 1982
Forman SJ, Spruce WE, Farbstein MJ, Wolf JL, Scott EP, Nademanee AP, Fahey JL, Hecht T, Zaia JA, Krance RA, Findley DO, Blume KG: Bone marrow ablation followed by allogeneic marrow grafting during first remission of acute nonlymphocytic leukemia. Blood 61:439–442,1983
Powles RL, Morgenstern G, Clink HM, Hedley D, Bandini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Jameson B, Lawler S, Kay HEM, McElwain TJ: The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet i: 1047–1050, 1980
Kersey JH, Ramsay NKG, Kim T, McGlave P, Krivit W, Levitt S, Filipovich A, Woods W, O’Leary M, Coccia P, Nesbit ME: Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: A pilot study. Blood 60:400–403, 1982
Mannoni P, Vernant JP, Rodet M, Rochant H, Bracq Ch, Tournesa A, Feuilhade F, Bierling P, Dreyfus B: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. Blut 41:220–225, 1980
Zwaan FE, Jansen J, Noordijk EM: Bone-marrow transplantation in acute myeloid leukemia (AML) during the first remission. The Leiden experience. Blut 41:216–220, 1980
Santos GW, Tutschka PJ, Brookmeyer R, Sarai R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM: Marrow transplantation for acute non lymphocytic leukemia treatment with busulfan and cyclophosphamide. N Engl J Med 309:1347–1353, 1983
Appelbaum FR, Cheever MA, Fefer A, Greenberg PD, Glucksberg H, Buckner CD, Thomas ED: A prospective study of the value of maintenance therapy or bone marrow transplantation (BMT) in adult acute nonlymphoblastic leukemia (ANL). Blood 60 (suppl 1): 163 a, 1982 (abstract # 581)
Kersey J, Ramsay N, Kim T, Woods W, McGlave P, Krivit W, Coccia P, Nesbit M for the University of Minnesota BMT Team: Bone marrow transplantation (BMT) in first remission in young patients with acute non-lymphocytic leukemia (ANNL), In: Proceedings of the Seventy-Second Annual Meeting of the Americal Association for Cancer Research, April 27–30, 1981 and Seventeenth Annual Meeting of the American Society of Clinical Oncology, April 30-May 2, 1981. Washington, D.C., 1981, p 143 (abstract # 568)
Deeg HJ, Storb R, Thomas ED, Kennedy MS, Flournoy N, Buckner CD, Clift R, Doney K, Sale G, Sanders J, Witherspoon R: Marrow transplantation for acute nonlymphoblastic leukemia in first remission: Preliminary results of a randomized trial comparing cyelosporine and methotrexate for the prophylaxis of graft-versus-host disease. Transplant Proc 15:1385–1388, 1983
Sokal JE: Evaluation of survival data for chronic myelocytic leukemia. Am J Hematol 1:493–500, 1976
Doney K, Buckner CD, Sale GE, Ramberg R, Boyd C, Thomas ED: Treatment of chronic granulocytic leukemia by chemotherapy, total body irradiation and allogeneic bone marrow transplantation. Exp Hematol 6:738–747, 1978
Fefer A, Cheever MA, Greenberg PD, Appelbaum FR, Boyd CN, Buckner CD, Kaplan HG, Ramberg R, Sanders JE, Storb R, Thomas ED: Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med 306:63–68, 1982
Clift RA, Buckner CD, Thomas ED, Doney K, Fefer A, Neiman PE, Singer J, Sanders J, Stewart P, Sullivan KM, Deeg J, Storb R: The treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet ii: 621–624, 1982
Goldman JM, McCarthy DM, Hows JM, Catovsky D, Goolden AW, Baughan AS, Worsley AM, Gordon-Smith EC, Batchelor JR, Galton DA: Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet ii: 623–625, 1982
McGlave PB, Kim TH, Hurd DD, Arthur DC, Ramsay NK, Kersey J: Successful allogeneic bone-marrow transplantation for patients in the accelerated phase of chronic granulocytic leukaemia, Lancet ii:625–627, 1982
Curtis JE, Messner HA: Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility. Can Med Assoc J 126:649–655, 1982
Speck B, Gratwohl A, Nissen C, Osterwalder B, Muller M, Bannert P, Muller Hj, Jeannet M: Allogeneic marrow transplantation for chronic granulocytic leukemia. Blut 45:237–242, 1982
Cheever MA, Fefer A, Greenberg PD, Appelbaum F, Armitage JO, Buckner CD, Sale GE, Storb R, Witherspoon RP, Thomas ED: Treatment of hairy cell leukemia with chemoradiotherapy and identical twin bone marrow transplantation. N Engl J Med 307:479–481, 1982
Boyd CN, Ramberg RC, Thomas ED: The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 6:833–837, 1982
Fialkow PJ, Thomas ED, Bryant JI, Neiman PE: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet i:251–255, 1971
Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman P, Ramberg RE, Storb R: Leukaemic transformation of engrafted human marrow cells in vivo. Lancet i:1310–1313,1972
Schubach WH, Hackman R, Neiman PE, Miller G, Thomas ED: A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic grafting for acute lymphoblastic leukemia. Blood, 60:180–187, 1982
Newburger PE, Latt SA, Pesando JM, Gustashaw K, Powers M, Chaganti RSK, O’Reilly RJ: Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. N Engl J Med 304:712–714, 1981
Gossett TC, Gale RP, Fleischman H, Austin GE, Sparkes RS, Taylor CR: Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N Engl J Med 300:904–907, 1979
Dinsmore R, Kirkpatrick D, Flomenberg N, Gulati S, Kapoor N, Shank B, Reid A, Groshen S, O’Reilly RJ: Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood 62:381–383, 1983
Coccia PF, Strandjord SE, Gordon EM, Novak, LF, Shina DC, Lazarus HM, Herzig RH: High dose cytosine arabinoside (Ara-C) and fractionated total body irradiation (F-TBI) as preparation for bone marrow transplantation (BMT) for childhood acute leukemia in remission-A preliminary report. Proceedings American Society of Clinical Oncology, 19th Annual Meeting, May 22–24, 1983, San Diego, California, 1983, p 175 (abstract # C-680)
Uphoff DE: Alteration of homograft reaction by A-methopterin in lethally irradiated mice treated with homologous marrow. Proc Soc Exp Biol Med 99:651–653, 1958
Storb R, Epstein RB, Graham TC, Thomas ED: Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 9:240–246, 1970
Weiden PL, Doney K, Storb R, Thomas ED: Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts. Transplant Proc 10:213–216, 1978
Santos GW, Sensenbrenner LL, Burke PJ, Mullins GM, Anderson PN, Tutschka PJ, Braine HG, Davis TE, Humphrey RL, Abeloff MD, Bias WB, Borgaonkar DS, Slavin RE: Allogeneic marrow grafts in man using cyclophosphamide. Transplant Proc 6:345–348, 1974
Ramsay NKC, Kersey JH, Robison LL, McGlave PB, Woods WG, Krivit W, Kim TH. Goldman AI, Nesbit ME Jr: A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med 306:392–397, 1982
Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients. Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267–276, 1981
Bortin MM: Graft versus leukemia. In: Bach FH, Good RA (eds): Clinical Immunobiology, vol 2. New York, Academic Press, 1974, pp 287–306
Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED, the Seattle Marrow Transplant Team: Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529–1533, 1981
Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT, Thomas ED and the Seattle Marrow Transplant Team: Protective environment for marrow transplant recipients. A prospective study. Ann Intern Med 89:893–901, 1978
Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD: Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 298:1052–1057, 1978
Meyers JD, Thomas ED: Infection complicating bone marrow transplantation, chap. 15. In: Rubin RH, Young LS (eds): Clinical Approach to Infection in the Immunocompromised Host. New York, Plenum Press, 1982, pp 507–551
Meyers JD, Flournoy N, Wade JC, Hackman RC, McDougall JK, Neiman PE, Thomas ED: Biology of interstitial pneumonia after marrow transplantation. In: Recent Advances in Bone Marrow Transplantation. New York, Alan R. Liss, Inc. 1983, pp 405–423
Meyers JD, Leszczynski J, Zaia JA, Flournoy N, Newton B, Snydman DR, Wright GG, Levin MJ, Thomas ED: Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 98:442–446, 1983
Winston DJ, Pollard RB, Ho WG, Gallagher JG, Rasmussen LE, Huang SN-Y, Lin C-H, Gossett TG, Merigan TC, Gale RP: Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 97:11–18, 1982
Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, Hodes MZ, Good RA, O’Reilly R: Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341–348, 1983
Prentice HG, Blacklock HA, Janossy G, Bradstock KF, Skeggs D, Goldstein G, Hoffbrand AV: Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet i:700–703, 1982
Filipovich AH, McGlave PB, Ramsay NKC, Goldstein G, Warkentin PI, Kersey JH: Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet i: 1266–1269, 1982
Martin PJ, Hansen JA, Remlinger K, Torok-Storb B, Storb R, Thomas ED: Murine monoclonal anti-human T cell antibodies for the prevention and treatment of graft-versus-host disease. In: Recent Advances in Bone Marrow Transplantation. New York, Alan R. Liss, Inc. 1983, pp 313–329
Clift RA, Hansen JA, Thomas ED, Buckner CD, Sanders JE, Mickelson EM, Storb R, Johnson FL, Singer JW, Goodell BW: Marrow transplantation from donors other than HLA-identical siblings. Transplantation 28:235–242, 1979
Hansen JA, Clift RA, Beatty PG, Mickelson EM, Nisperos B, Martin PJ, Thomas ED: Marrow transplantation from donors other than HLA genotypically identical siblings. In: Recent Advances in Bone Marrow Transplantation. New York, Alan R. Liss, Inc. 1983, pp 739–756
Powles RL, Morgenstern GR, Kay HEM, McElwain TJ, Clink HM, Dady PJ, Barrett A, Jameson B, Depledge MH, Watson JG, Sloane J, Leigh M, Lumley H, Hedley D, Lawler SD, Filshie J, Robinson B: Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet i:612–615, 1983
Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303:565–567, 1980
Gordon-Smith EC, Fairhead SM, Chipping PM, Hows J, James DCO, Dodi A, Batchelor JR: Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. Br Med J 285:835–837, 1982
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer: Berlin Heidelberg
About this paper
Cite this paper
Thomas, E.D. (1984). Bone Marrow Transplantation for Leukemia. In: Büchner, T., Urbanitz, D., van de Loo, J. (eds) Therapie der akuten Leukämien. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69934-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-69934-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13682-8
Online ISBN: 978-3-642-69934-4
eBook Packages: Springer Book Archive